ARTELO BIOSCIENCES, INC. Operating Lease, Liability, Current
ARTELO BIOSCIENCES, INC. (ARTL) had Operating Lease, Liability, Current of $42.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-12
- 2026-06-30: Operating Lease, Liability, Current $42.00K.
- 2026-03-31: Operating Lease, Liability, Current $41.00K.
- 2025-12-31: Operating Lease, Liability, Current $40.00K.
- 2025-09-30: Operating Lease, Liability, Current $39.00K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $42.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $41.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $40.00K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $39.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $36.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $36.00K 8-K · filed 2025-07-11 |
| 2024-12-31 | $35.00K 8-K · filed 2026-03-17 |
| 2024-09-30 | $34.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $33.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $31.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $23.00K 8-K · filed 2025-07-11 |
| 2023-09-30 | $32.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $34.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $37.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $40.00K 10-K · filed 2024-03-25 |
| 2022-09-30 | $42.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $45.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $32.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $31.00K 10-K · filed 2023-03-31 |
| 2021-11-30 | $31.00K 10-Q · filed 2022-01-12 |
| 2021-08-31 | $28.00K 10-K · filed 2023-03-31 |
| 2020-08-31 | $0.00 10-KT · filed 2022-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |